SCOTTISH ENTERPRISE

Mangata Networks Announces $33 Million Series A Raise Launching Innovative Satellite/Edge Computing Network

Retrieved on: 
Wednesday, January 12, 2022

Mangata Networks has closed a $33 million Series A round led by US-based venture capital firm Playground Global to continue its mission to transform the way the world interacts with information.

Key Points: 
  • Mangata Networks has closed a $33 million Series A round led by US-based venture capital firm Playground Global to continue its mission to transform the way the world interacts with information.
  • This single core network will provide scalable B2G and B2B connectivity, that is both affordable and accessible to anyone, anywhere on the planet.
  • Mangata Networks will initiate service for the entire Northern Hemisphere starting in 2024 with its initial launch of 8 HEO satellites.
  • Using a proprietary network of satellites and terrestrial systems, Mangata is connecting people, machines, and devices across the world.

ILC Therapeutics Announces Successful Completion of £3.5m Funding Round

Retrieved on: 
Monday, September 6, 2021

ILC Therapeutics, a UK-based biotechnology company and pioneer in the discovery and development of a ground-breaking new class of interferon drugs, announces the successful completion of a 3.5m pre- IPO funding round.

Key Points: 
  • ILC Therapeutics, a UK-based biotechnology company and pioneer in the discovery and development of a ground-breaking new class of interferon drugs, announces the successful completion of a 3.5m pre- IPO funding round.
  • Chairman Peter Bains said: We are very pleased to complete this important funding round and to strengthen the Board with the appointment of Robert Kopple, Professor David Harrison and Chris Brinsmead.
  • ILC Therapeutics Ltd is an emerging biotechnology company focused on modulating the innate immune system through the design and development of novel hybrid interferon drug candidates.
  • For more information on ILC Therapeutics, please visit: www.ilctherapeutics.com
    Follow ILC Therapeutics on LinkedIn: www.linkedin.com/company/ilctherapeutics/
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210906005255/en/